Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

1.88
Delayed Data
As of 12:33pm ET
 +0.03 / +1.62%
Today’s Change
1.20
Today|||52-Week Range
8.22
+21.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues290.3K175.0K382.0K158.3K
 
 
 
 
 
Depreciation And Amortization1.8M1.3M2.3M3.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.4M47.5M82.0M82.5M
 
 
 
 
 
Research And Development8.7M23.1M47.3M41.5M
 
 
 
 
 
Total Operating Expenses22.1M48.8M84.3M85.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.9M-48.6M-83.9M-85.6M
 
 
 
 
 
Extraordinary Credit0.00--2.9M5.9M
 
 
 
Extraordinary Charge-8.0M-10.7M-12.0M-2.4M
 
 
 
 
 
Pre-Tax Equity Earnings-641.1K-78.9K0.000.00
 
 
 
Interest Expense On Debt97.9K0.000.000.00
 
 
Other Expenses-1.1M23.2K437.1K57.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.7M-58.7M-91.9M-81.7M
 
 
 
 
 
Income Taxes0.00-5.3K-2.4K-2.4K
 
 
 
 
Minority Interest-560.1K-95.2K0.000.00
 
 
 
Discontinued Operations-354.000.000.000.00
 
 
Net Income-31.1M-58.6M-91.9M-81.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.0M46.9M57.4M61.1M
 
 
 
 
 
Shares To Calculate EPS Diluted24.0M46.9M57.4M61.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.30-$1.25-$1.60-$1.34
 
 
 
 
 
EPS Diluted-$1.30-$1.25-$1.60-$1.34